Decentralized Trials STREAM

31. Patient First Solutions For Oncology 2/14/2023

    Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

32. Leveraging DHTs To Improve Data Collection And Analysis 2/25/2025

    How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

33. The New Vaccine Race: Why A Decentralized Approach Wins 3/29/2022

    What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.

34. Medable Total Consent: The Future Of Informed Consent 2/14/2023

    With Total Consent, Medable is transforming the consenting process – harmonizing it into one simple-to-use platform that enables trial sponsors and CROs to completely customize eConsent.

35. Clinical Trials From Home: The Role Of Research Nurses 8/26/2022

    In this presentation, speakers shed light on the advantages of home visits for clinical trials and what research nurses do to make this possible.

36. Transformative Cardiac Solutions 7/30/2025

    While traditional ECGs require on-site visits, delaying data and increasing drop-out risk, AliveCor''s FDA-Cleared ECG devices can be used on-site as well as in decentralized and fully remote trials.

37. Creating The Digital Foundation For Scale In Clinical Development 8/11/2023

    Learn how CROs, pharma, and biotechs are using digital trial methods to scale efficiencies across the entirety of their clinical trial portfolio for maximum ROI.

38. The Platform Shift is Here: Are you Realizing ROI Across your Portfolio of Studies? 9/20/2022

    Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.